BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets

  May 7, 2025

   · 

  2 min read
• Press Releases

  Palatin Technologies Announces Pricing of up to $23 Million Public Offering

  May 7, 2025

   · 

  5 min read
• Press Releases

  Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings

  May 7, 2025

   · 

  4 min read
• Press Releases

  Amylyx Pharmaceuticals to Participate in Upcoming May Investor Conferences

  May 7, 2025

   · 

  1 min read
• Press Releases

  Imperative Care Launches its Next Innovation to Elevate Ischemic Stroke Treatment and Announces First Patients Treated with Continuous Dual Aspiration Technique

  May 7, 2025

   · 

  4 min read
• Press Releases

  Neptune Medical Announces New Data Demonstrating That Pathfinder Endoscope Overtube Enables Completion of Diagnostic and Therapeutic Procedures in Challenging Anatomy

  May 7, 2025

   · 

  3 min read
• Press Releases

  Avvio Medical Announces First Patients Treated with Groundbreaking Kidney Stone Therapy

  May 7, 2025

   · 

  2 min read
• Press Releases

  Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development

  May 7, 2025

   · 

  2 min read
• Press Releases

  Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

  May 7, 2025

   · 

  8 min read
• Press Releases

  Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC

  May 7, 2025

   · 

  4 min read